Floriparicapitus n. gen. (Cestoda: Lecanicephalidea), with Floriparicapitus euzeti n. gen., n. sp. as its type, is erected to house 3 new tapeworm species and 2 known species that are transferred to the new genus, all parasitizing sawfishes and guitarfishes (order Rhinopristiformes) in Indo-Pacific waters. The new genus differs from the 21 valid lecanicephalidean genera in its possession of a large scolex bearing a laterally expanded apical organ in the form of a rugose sheet in combination with a cirrus conspicuously armed with spinitriches and 3 pairs of excretory vessels. It most closely resembles Lecanicephalum, but differs conspicuously in its possession of 3, rather than 1, pair of excretory vessels. Two new species are described from sawfishes: Floriparicapitus euzeti n. sp., from Pristis clavata and Floriparicapitus juliani n. sp. from Pristis pristis, both from Australia. Floriparicapitus plicatilis n. sp. is described from the guitarfish Glaucostegus typus in Australia and the guitarfish Glaucostegus thouin in Malaysian Borneo. Two species formerly assigned to Cephalobothrium are transferred to the new genus; Floriparicapitus variabilis (Southwell, 1911) n. comb. from the sawfish Anoxypristis cuspidata in Sri Lanka and Floriparicapitus rhinobatidis (Subhapradha, 1955) n. comb. from the guitarfish Glaucostegus granulatus in India. The species from guitarfish differ conspicuously from those parasitizing sawfish in their possession of only 4 (F. plicatilis n. sp.) or 5 (F. rhinobatidis n. comb.) testes per proglottid versus 9 or more in the 3 sawfish-parasitizing species. The latter 3 species differ from one another in scolex width, acetabular size, number of proglottids, and cirrus sac size. As it stands, the new genus appears to be restricted to a subclade of the Rhinopristiformes consisting of the sawfishes and species of Glaucostegus.
You have requested a machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Neither BioOne nor the owners and publishers of the content make, and they explicitly disclaim, any express or implied representations or warranties of any kind, including, without limitation, representations and warranties as to the functionality of the translation feature or the accuracy or completeness of the translations.
Translations are not retained in our system. Your use of this feature and the translations is subject to all use restrictions contained in the Terms and Conditions of Use of the BioOne website.
Vol. 100 • No. 4